Keyphrases
Apoptosis
100%
Bladder Cancer Cells
100%
Ciprofloxacin
100%
Bladder Transitional Cell Carcinoma
100%
Cell Growth Inhibition
100%
G2-M Cell Cycle Arrest
100%
P21Cip1
44%
Cyclin-dependent Kinase 2 (CDK2)
22%
Tumor Cells
22%
Therapeutic Agents
22%
Bladder Cancer
22%
Mitomycin C
11%
Cell Growth
11%
Cell Cycle Arrest
11%
In Vitro Study
11%
B-cell Lymphoma 2 (Bcl-2)
11%
Middle-aged
11%
Dephosphorylation
11%
Biological Effects
11%
Apoptotic Cell Death
11%
In Vitro Cells
11%
Cell-derived
11%
Apoptosis Induction
11%
Cancer Management
11%
Antibiotics
11%
Elderly People
11%
Caspase-3
11%
Novel Mechanism
11%
Urinary Tract
11%
Recurrence Rate
11%
Tumor Cell Proliferation
11%
Cyclin E
11%
Bladder Tumor
11%
Inhibit Tumor
11%
Cisplatin
11%
Thiotepa
11%
Mitochondrial Depolarization
11%
Cyclin-dependent Kinase Inhibitor p21
11%
Bacillus Calmette-Guérin
11%
Time-dependent Inhibition
11%
Intravesical
11%
Apoptotic Cascade
11%
Adriamycin
11%
Poly(ADP-ribose) Polymerase
11%
Transitional Cell Carcinoma
11%
G2-M Checkpoint
11%
Urological Malignancies
11%
Cyclin B
11%
Fluroquinolones
11%
Found down
11%
Immunology and Microbiology
Carcinoma Cell
100%
Cell Growth
100%
Growth Inhibition
100%
Cell Cycle Arrest
100%
Cell Cycle Checkpoint
100%
Bladder Cell Line
100%
Programmed Cell Death
100%
Tumor Cell
60%
Downregulation
60%
Cancer Cell
20%
Urinary Tract
20%
Caspase
20%
Cycline
20%
Upregulation
20%
Mycobacterium Bovis BCG
20%
Bcl-2
20%
Dephosphorylation
20%
Time-Dependent Inhibition
20%
Cyclin E
20%
Cyclin B
20%
Biological Activity
20%
Pharmacology, Toxicology and Pharmaceutical Science
Transitional Cell Carcinoma
100%
Ciprofloxacin
100%
Bladder Cancer
33%
Neoplasm
11%
Tumor Growth
11%
Antibiotics
11%
Procaspase 3
11%
Cisplatin
11%
Cyclin E
11%
Recurrence Risk
11%
Mycobacterium Bovis BCG
11%
Doxorubicin
11%
Thiotepa
11%
Mitomycin
11%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
11%
Bladder Tumor
11%
Cyclin Dependent Kinase Inhibitor 1A
11%
Cyclin B
11%